<rss version="2.0"><channel><title>BioSpace.com News</title><link>http://www.biospace.com</link><generator>BioSpace RSS Generator</generator><lastBuildDate>Wed, 19 Jun 2013 09:24:07 GMT</lastBuildDate><ttl>20</ttl><image><url>http://rss.biospace.com/images/BSPLogo.gif</url><title>BioSpace.com</title><link>http://www.BioSpace.com/news.aspx?SectionId=1</link></image><copyright>Copyright (C) 2011</copyright><item><title>UCB Group Receives Not-approvable Letter from FDA for Lacosamide for Diabetic Neuropathic Pain  </title><link>http://www.biospace.com/news_story.aspx?StoryID=105005&amp;full=1</link><description>BRUSSELS, BELGIUM--(Marketwire - July 29, 2008) - 6 pm CEST - press release, regulated information: UCB announced today that it received a not-approvable letter from the U.S. Food and Drug Administration (FDA) for lacosamide for the treatment of diabetic neuropathic pain in adults. &lt;/p&gt;&lt;p&gt;The company will seek clarification from the FDA of its position and of the additional information required...</description><pubDate>Wed, 30 Jul 2008 12:00:00 AM GMT</pubDate></item></channel></rss>